X

Trial Profile

Confirmatory phase IIb study evaluating topical clonidine gel for painful diabetic neuropathy

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 04 Dec 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clonidine (Primary)
Indications Diabetic neuropathies; Neuropathic pain
Focus Therapeutic Use

Most Recent Events

02 Dec 2013 Status changed from planning to discontinued, according to a BioDelivery Sciences International media release announcing that the company is proceeding to phase III trials instead of this confirmatory phase IIb trial.
03 Apr 2013 New trial record
26 Mar 2013 Data may be potentially available before the end of 2014, according to a BioDelivery Sciences International media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com